Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

459 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.
Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, Drexel H, Patak A, Torp-Pedersen C, Kjeldsen KP, Tamargo J. Rosano GM, et al. Among authors: tamargo j. Eur Heart J. 2015 Oct 21;36(40):2677-80. doi: 10.1093/eurheartj/ehv161. Epub 2015 May 6. Eur Heart J. 2015. PMID: 25948737 Review. No abstract available.
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis.
Niessner A, Tamargo J, Morais J, Koller L, Wassmann S, Husted SE, Torp-Pedersen C, Kjeldsen K, Lewis BS, Drexel H, Kaski JC, Atar D, Storey RF, Lip GYH, Verheugt FWA, Agewall S. Niessner A, et al. Among authors: tamargo j. Eur Heart J. 2017 Jun 7;38(22):1710-1716. doi: 10.1093/eurheartj/ehv676. Eur Heart J. 2017. PMID: 26705385 No abstract available.
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Schmidt M, Lamberts M, Olsen AM, Fosbøll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C. Schmidt M, et al. Among authors: tamargo j. Eur Heart J. 2016 Apr 1;37(13):1015-23. doi: 10.1093/eurheartj/ehv505. Epub 2016 Mar 16. Eur Heart J. 2016. PMID: 26984863 Review. No abstract available.
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.
Zannad F, Stough WG, Lipicky RJ, Tamargo J, Bakris GL, Borer JS, Alonso García Mde L, Hadjadj S, Koenig W, Kupfer S, McCullough PA, Mosenzon O, Pocock S, Scheen AJ, Sourij H, Van der Schueren B, Stahre C, White WB, Calvo G. Zannad F, et al. Among authors: tamargo j. Eur Heart J Cardiovasc Pharmacother. 2016 Jul;2(3):200-5. doi: 10.1093/ehjcvp/pvw007. Epub 2016 Apr 3. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27418973 Free PMC article. Review.
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Schmidt M, Lamberts M, Olsen AM, Fosbøll EL, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C. Schmidt M, et al. Among authors: tamargo j. Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):108-18. doi: 10.1093/ehjcvp/pvv054. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27533522 No abstract available.
Comprehensive efforts to increase adherence to statin therapy.
Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, Funck-Brentano C, Kaski JC, Niessner A, Tamargo J, Walther T, Wassmann S, Rosano G, Schmidt H, Saely CH, Drexel H. Vonbank A, et al. Among authors: tamargo j. Eur Heart J. 2017 Aug 21;38(32):2473-2479. doi: 10.1093/eurheartj/ehw628. Eur Heart J. 2017. PMID: 28077470 No abstract available.
Gender differences in the effects of cardiovascular drugs.
Tamargo J, Rosano G, Walther T, Duarte J, Niessner A, Kaski JC, Ceconi C, Drexel H, Kjeldsen K, Savarese G, Torp-Pedersen C, Atar D, Lewis BS, Agewall S. Tamargo J, et al. Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):163-182. doi: 10.1093/ehjcvp/pvw042. Eur Heart J Cardiovasc Pharmacother. 2017. PMID: 28329228 Review.
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Niessner A, Tamargo J, Koller L, Saely CH, Schmidt TA, Savarese G, Wassmann S, Rosano G, Ceconi C, Torp-Pedersen C, Kaski JC, Kjeldsen KP, Agewall S, Walther T, Drexel H, Lewis BS. Niessner A, et al. Among authors: tamargo j. Eur Heart J. 2018 Jun 21;39(24):2274-2281. doi: 10.1093/eurheartj/ehx625. Eur Heart J. 2018. PMID: 29126266 No abstract available.
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).
Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Gorenek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumura K, Piccini JP, Potpara T, Poulsen BK, Saba M, Savelieva I, Tamargo JL, Wolpert C; ESC Scientific Document Group. Dan GA, et al. Europace. 2018 May 1;20(5):731-732an. doi: 10.1093/europace/eux373. Europace. 2018. PMID: 29438514 No abstract available.
459 results